Pasco Julie A, Berk Michael, Penninx Brenda, Hyde Natalie K, Holloway-Kew Kara L, West Emma C, Kotowicz Mark A, Anderson Kara B, O'Neil Adrienne, Rufus-Membere Pamela G, Williams Lana J
Deakin University, IMPACT - Institute for Mental and Physical Health and Clinical Translation, Barwon Health, Geelong, VIC, Australia.
Department of Medicine-Western Health, The University of Melbourne, St. Albans, VIC, Australia.
Front Nutr. 2023 Sep 28;10:1222019. doi: 10.3389/fnut.2023.1222019. eCollection 2023.
We aimed to determine women's risk of major depressive disorder (MDD) in relation to obesity phenotypes characterized by levels of circulating high-sensitivity C-reactive protein (hsCRP).
This population-based retrospective cohort study comprised 808 women (ages 20-84 y) recruited 1994-1997 and followed for a median 16.1 y (IQR 11.9-16.8). At baseline, body fat and lean tissue mass were measured by whole body dual-energy x-ray absorptiometry (DXA). Obesity was identified as high fat mass index (>12.9 kg/m), body fat percentage (≥35%) and body mass index (≥30 kg/m); sarcopenic obesity referred to a high ratio fat mass/fat-free mass (≥0.80). Systemic inflammation was operationalized as serum hsCRP concentration in the upper tertile (>2.99 mg/L). Obesity phenotypes were: non-obese + lowCRP, non-obese + highCRP, obese + lowCRP, and obese + highCRP. During follow-up, the Structured Clinical Interview for DSM-IV-TR (SCID-I/NP) was used to identify lifetime history of MDD and age of onset. Poisson regression models were used to estimate the MDD rate for each obesity phenotype during follow-up. Demographic, health and lifestyle factors were tested as potential confounders.
During 11,869 p-y of follow-up, 161 (19.9%) women experienced an MDD episode. For obesity phenotypes based on fat mass index, models adjusted for baseline age and prior MDD, and non-obese + lowCRP as reference, RR for non-obese + highCRP was 1.21 (95% CI 0.80, 1.82), obese + lowCRP 1.46 (0.86, 2.47) and obese + highCRP 1.56 (1.03, 2.37). Patterns were similar for obesity by body fat percentage, body mass index and sarcopenic obesity.
Consistently across different obesity definitions, this longitudinal study reports that women with both obesity and systemic inflammation are at increased risk of subsequent MDD. Future research should examine whether tackling this metabolically unhealthy obesity type - through, for example, lifestyle or medication approaches - can reduce depression risk.
我们旨在确定女性患重度抑郁症(MDD)的风险与以循环高敏C反应蛋白(hsCRP)水平为特征的肥胖表型之间的关系。
这项基于人群的回顾性队列研究纳入了1994年至1997年招募的808名女性(年龄20 - 84岁),中位随访时间为16.1年(四分位间距11.9 - 16.8年)。在基线时,通过全身双能X线吸收法(DXA)测量体脂肪和瘦组织质量。肥胖被定义为高脂肪质量指数(>12.9 kg/m)、体脂百分比(≥35%)和体重指数(≥30 kg/m);肌少性肥胖指脂肪质量/去脂体重比值高(≥0.80)。全身性炎症定义为血清hsCRP浓度处于上三分位数(>2.99 mg/L)。肥胖表型分为:非肥胖 + 低CRP、非肥胖 + 高CRP、肥胖 + 低CRP和肥胖 + 高CRP。在随访期间,使用DSM-IV-TR结构化临床访谈(SCID-I/NP)来确定MDD的终生病史和发病年龄。采用泊松回归模型估计随访期间每种肥胖表型的MDD发生率。对人口统计学、健康和生活方式因素进行测试,以确定其是否为潜在混杂因素。
在11869人年的随访期间,161名(19.9%)女性经历了一次MDD发作。对于基于脂肪质量指数的肥胖表型,在对基线年龄和既往MDD进行调整的模型中,以非肥胖 + 低CRP为参照,非肥胖 + 高CRP的风险比(RR)为1.21(95%置信区间0.80,1.82),肥胖 + 低CRP为1.46(0.86,2.47),肥胖 + 高CRP为1.56(1.03,2.37)。通过体脂百分比、体重指数和肌少性肥胖定义的肥胖情况,其模式相似。
在不同的肥胖定义中,该纵向研究一致报告,肥胖且伴有全身性炎症的女性患后续MDD的风险增加。未来的研究应探讨通过例如生活方式或药物治疗等方法应对这种代谢不健康的肥胖类型是否可以降低抑郁风险。